Ropes & Gray Represents Sanofi in Investment in AgomAb Therapeutics
October 29, 2024
October 29, 2024
BOSTON, Massachusetts, Oct. 29 -- Ropes and Gray, a law firm, issued the following news:
Ropes & Gray represented Sanofi as it participated in AgomAb Therapeutics' $89 million Series D financing round.
AgomAb is an Antwerp, Belgium-based biopharma company focused on achieving disease modification by modulating fibrosis and regeneration in chronic indications such as fibrostenosing Crohn's disease and idiopathic pulmonary fibrosis.
The transact . . .
Ropes & Gray represented Sanofi as it participated in AgomAb Therapeutics' $89 million Series D financing round.
AgomAb is an Antwerp, Belgium-based biopharma company focused on achieving disease modification by modulating fibrosis and regeneration in chronic indications such as fibrostenosing Crohn's disease and idiopathic pulmonary fibrosis.
The transact . . .